After obtaining her PhD in Toulouse in 2020 in the field of pathology and toxicology, Mélissa Parny joined the RESTORE laboratory to carry out her postdoctorate in the discovery of a food supplement that would reduce the development of osteoarthritis using different histochemical techniques on bone joint. She then integrated the LABHPEC (Laboratory of Experimental and Comparative Histopathology) as a research engineer. LABHPEC is part of the national infrastructure ECellFrance, which is the first GLP-compliant academic histopathology laboratory (since 2017) carrying out regulatory safety studies for private and public sponsors, particularly in the field of ATMPs (Advance Therapy Medicinal Product). In this GLP framework, Melissa is recruited as Director of non-clinical trials.